SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-19-011147
Filing Date
2019-08-23
Accepted
2019-08-23 16:02:47
Documents
14
Period of Report
2019-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A a20190823-8ka.htm   iXBRL 8-K/A 41736
  Complete submission text file 0001628280-19-011147.txt   188242

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bold-20190823_cal.xml EX-101.CAL 624
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bold-20190823_def.xml EX-101.DEF 1474
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bold-20190823_lab.xml EX-101.LAB 27201
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bold-20190823_pre.xml EX-101.PRE 14099
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bold-20190823.xsd EX-101.SCH 4588
7 EXTRACTED XBRL INSTANCE DOCUMENT a20190823-8ka_htm.xml XML 4912
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37833 | Film No.: 191049147
SIC: 2836 Biological Products, (No Diagnostic Substances)